Table 4.

Clinical Characteristics of the Study Participants and FACT-B Quality of Life Scores

Variables	PWB	SWB	EWB	FWB	BCS	TQOL
	Mean ± SD	Mean ± SD	Mean ± SD	Mean ± SD	Mean ± SD	Mean ± SD
Age at Diagnosis
≤50	22.58 ± 4.58	21.64 ± 5.00	18.98 ± 3.82	21.49 ± 4.98	23.01 ± 6.06*	107.70 ± 18.44
>50	22.67 ± 4.77	21.79 ± 4.55	18.85 ± 4.42	21.49 ± 4.42	25.18 ± 6.08	109.99 ± 19.23
Years Since Diagnosis
≤ 2 years	24.10 ± 4.00	22.73 ± 4.02	19.55 ± 3.71	23.00 ± 4.08	24.13 ± 4.68	113.51 ± 14.08
3 to ≤ 5 years	22.51 ± 4.78	21.51 ± 4.88	18.76 ± 4.18	21.60 ± 4.63	24.12 ± 6.14	108.50 ± 19.33
>5 years	21.93 ± 4.50	21.71 ± 5.01	19.07 ± 4.08	19.96 ± 5.23Ŧ	23.34 ± 7.23	106.01 ± 19.54
Stage
0 or I or II	23.11 ± 4.18	21.69 ± 4.97	19.26 ± 3.72	21.54 ± 4.82	24.29 ± 5.73	109.89 ± 17.83
III	22.37 ± 5.29	22.43 ± 4.02	18.74 ± 4.77	22.23 ± 4.83	23.43 ± 7.39	109.20 ± 21.88
IV	19.46 ± 5.39	19.88 ± 5.08	16.69 ± 4.42	19.15 ± 2.79	23.05 ± 5.92	98.24 ± 14.53*
Surgery
Yes	22.72 ± 4.57	21.81 ± 4.76	19.03 ± 4.03	21.62 ± 4.71	24.01 ± 6.17	109.18 ± 18.73
No	19.00 ± 6.93	17.83 ± 4.93	15.00 ± 4.83	17.00 ± 2.94*	23.06 ± 5.93	91.89 ± 12.02
Chemotherapy
Yes	21.94 ± 4.76*	21.53 ± 4.85	18.66 ± 4.20	21.31 ± 4.85	23.20 ± 6.05*	106.65 ± 19.05*
No	25.23 ± 3.04	22.38 ± 4.57	19.90 ± 3.51	22.19 ± 4.20	26.99 ± 5.65	116.69 ± 15.46
Radiotherapy
Yes	22.20 ± 4.87*	21.79 ± 4.94	18.78 ± 4.21	21.31 ± 4.67	23.51 ± 6.33*	107.58 ± 19.48
No	24.38 ± 3.08	21.37 ± 4.18	19.52 ± 3.50	22.28 ± 4.97	25.94 ± 4.93	113.48 ± 14.81
Hormonal Therapy
Yes	22.76 ± 4.39	21.72 ± 4.88	19.05 ± 3.79	21.50 ± 4.79	24.04 ± 5.99	109.06 ± 18.04
No	21.76 ± 6.07	21.63 ± 4.26	18.14 ± 5.61	21.48 ± 4.39	23.63 ± 7.22	106.64 ± 23.13
Family History of Breast Cancer
Yes	22.70 ± 4.16	21.70 ± 4.79	19.21 ± 3.32	21.66 ± 4.25	23.91 ± 6.04	109.19 ± 15.79
No	22.57 ± 4.94	21.71 ± 4.81	18.74 ± 4.48	21.39 ± 5.01	24.02 ± 6.24	108.44 ± 20.41

PWB, Physical Well-Being; SWB, Social Well-Being; EWB, Emotional Well-Being; Functional Well-Being; BCS, Breast Cancer Subscale; TQOL, Total Quality of Life.

^*Significantly lower scores compared to all other cohorts within each demographic category for each score;

^ŦSignificantly lower FWB scores compared to ≤ 2 years post-diagnosis cohort.